Mechanistic Studies of B- and T-Cell Function in RA Patients Treated With TNF Antagonists, Tocilizumab, or Abatacept

NCT02353780 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

10

Enrollment

OTHER

Sponsor class

Stopped Low enrollment

Conditions

Rheumatoid Arthritis (RA)

Interventions

DRUG: TNF Antagonist (enbrel, humire, remicade, cimzia, symponi)
DRUG: Abatacept
DRUG: Tocilizumab

Sponsor

Dr. Larry W. Moreland

Collaborators

[object Object]
[object Object]